TMPRSS2 and prostate cancer: Collectively, these findings imply that the overexpression of the ETS transcription factors, resulting from chromosomal rearrangements involving the TMPRSS2 genetic elements, represents a crucial facet of the molecular pathology of prostate cancer [27].